SE8008500L - Vaccin for bekempning av pleuropneumoni i svin och ett forfarande och ett substrat for aerob fermentering av haemophilus pleuropneumoniae - Google Patents

Vaccin for bekempning av pleuropneumoni i svin och ett forfarande och ett substrat for aerob fermentering av haemophilus pleuropneumoniae

Info

Publication number
SE8008500L
SE8008500L SE8008500A SE8008500A SE8008500L SE 8008500 L SE8008500 L SE 8008500L SE 8008500 A SE8008500 A SE 8008500A SE 8008500 A SE8008500 A SE 8008500A SE 8008500 L SE8008500 L SE 8008500L
Authority
SE
Sweden
Prior art keywords
pleuropneumoniae
substrate
vaccine
new
improved
Prior art date
Application number
SE8008500A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
J Fogh
B Nielsen
H-J Riising
Original Assignee
Nordisk Droge & Kemikalie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Droge & Kemikalie filed Critical Nordisk Droge & Kemikalie
Publication of SE8008500L publication Critical patent/SE8008500L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8008500A 1979-04-04 1980-12-03 Vaccin for bekempning av pleuropneumoni i svin och ett forfarande och ett substrat for aerob fermentering av haemophilus pleuropneumoniae SE8008500L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK138379A DK138379A (da) 1979-04-04 1979-04-04 Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae

Publications (1)

Publication Number Publication Date
SE8008500L true SE8008500L (sv) 1980-12-03

Family

ID=8104263

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8008500A SE8008500L (sv) 1979-04-04 1980-12-03 Vaccin for bekempning av pleuropneumoni i svin och ett forfarande och ett substrat for aerob fermentering av haemophilus pleuropneumoniae

Country Status (10)

Country Link
EP (1) EP0026209A1 (fr)
JP (1) JPS56500339A (fr)
AT (1) ATA903480A (fr)
BE (1) BE882619A (fr)
DK (1) DK138379A (fr)
GB (1) GB2057882B (fr)
IE (1) IE49754B1 (fr)
NL (1) NL8020132A (fr)
SE (1) SE8008500L (fr)
WO (1) WO1980002113A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA873698B (en) * 1986-05-23 1987-11-18 Midcon Labs, Inc. Co-vaccination using non-o-carbohydrate side-chain gram-negative bacteria preparation
NL8802007A (nl) * 1988-08-12 1990-03-01 Centraal Diergeneeskundig Inst Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins.
FR2652266B1 (fr) * 1989-09-26 1994-08-12 Rhone Merieux Vaccin protecteur contre l'hemophilose porcine.
EP0453024B1 (fr) * 1990-04-20 1995-05-31 Akzo Nobel N.V. Vaccin de sous-unités d'actinobacillus pleuropneumoniae
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
AU2009100018B4 (en) * 2008-10-15 2009-09-03 Australasian Pork Research Institute Ltd A Method of vaccination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質

Also Published As

Publication number Publication date
IE800696L (en) 1980-10-04
WO1980002113A1 (fr) 1980-10-16
GB2057882A (en) 1981-04-08
NL8020132A (nl) 1981-01-30
JPS56500339A (fr) 1981-03-19
GB2057882B (en) 1983-05-18
DK138379A (da) 1980-10-05
ATA903480A (de) 1984-05-15
BE882619A (fr) 1980-10-03
IE49754B1 (en) 1985-12-11
EP0026209A1 (fr) 1981-04-08

Similar Documents

Publication Publication Date Title
JPS54147997A (en) Novel hyaluronidase bmp-8231 and its preparation
Rowatt The growth of Bordetella pertussis: a review
JPH02196780A (ja) グリコシダーゼ阻害剤サルボスタチンおよびその製法
SE8008500L (sv) Vaccin for bekempning av pleuropneumoni i svin och ett forfarande och ett substrat for aerob fermentering av haemophilus pleuropneumoniae
Wessman et al. Toxic effect of glucose on virulent Pasteurella pestis in chemically defined media
US4656037A (en) SPF-100 and process for the preparation thereof
JPS5743685A (en) L-glutamic oxidase
Seddon et al. A chemically defined and minimal medium for Clostridium difficile
JPS56125397A (en) Oligosaccharide derivative, its preparation and preventing agent against decayed tooth containing the same as active constituent
Shigidi et al. Characterisation of Nocardia farcinica isolated from cattle with bovine farcy
CN102171362B (zh) 用于在富含二氧化碳的空气供应下在液体培养基中生产胸膜炎肺炎放线杆菌毒素apxi或apxiii的过程
JPS572684A (en) Preparation of amylase inhibitor ai-b
JP3747640B2 (ja) 光学活性１，２−ジオール環状炭酸エステルの製造法
JPS5765177A (en) Cultivation of fungi
SU1163636A1 (ru) Штамм ацидофильных метилотрофных бактерий @ @ ВСБ-924-продуцент белка
Schlecht et al. Influence of the glucose concentration on the yield of biomass and lipopolysaccharide in Salmonella cultures
JPS5594393A (en) Gluco-corticoid sparing factor
JPS6251999A (ja) ヒアルロン酸の製造法
JPS57132880A (en) Preparation of choline oxidase by fermentation method
Shankar The Effect of Magnesium on the Growth and Metabolism of Clostridium Perfringens
Griffith et al. Nicotine Oxidation by Arthrobacter
Scheff et al. 11. CULTURE OF T. PALLIDUM IN VITRO: IV. GROWTH REQUIREMENTS
JPS61173792A (ja) メナキノン−４の製造法
JPS5945894A (ja) 補酵素ｑ↓１↓０の製造法
JPS5519070A (en) Preparation of benikoji pigment

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8008500-4

Format of ref document f/p: F